Overview

Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer

Status:
Terminated

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to assess the benefit of panobinostat monotherapy given either orally or i.v. to women with HER2-positive locally recurrent or metastatic breast cancer

Phase:

Phase 2

Details

Lead Sponsor:

Translational Research in Oncology

Treatments:

Panobinostat